SCHEMBL2768019

SCHEMBL2768019

COc1ccc(N2CCC(Cc3ccccc3)CC2)c(C#N)c1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.53
HTR1A P08908 2/20 0.53
SLC6A4 P31645 2/20 0.50
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
POLB P06746 1/20 0.49
GRIN1 Q05586 1/20 0.48
GRIN2B Q13224 1/20 0.48
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
GAA P10253 1/20 0.48
HPGD P15428 1/20 0.48
TSHR P16473 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
HSD17B10 Q99714 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
SLC6A2 P23975 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2766536 0.86 OPRM1 (0.46) HTR1ASLC6A4GAAHSD17B10
SCHEMBL2768386 0.81 MAPT (0.49) HTR1AMEN1KMT2AKDM4EALDH1A1
SCHEMBL2767981 0.81 MAPT (0.48) SLC6A4MEN1KMT2AGRIN1GRIN2B
SCHEMBL2769508 0.79 ADRA1D (0.58) SIGMAR1HTR1ASLC6A4
SCHEMBL15831837 0.78 FFAR4 (0.54) SLC6A4MEN1KMT2AGRIN2BLMNA
SCHEMBL12835681 0.77 MAPT (0.52) MEN1KMT2AKDM4EALDH1A1GAA
Hydrochloric Acid SCHEMBL1514470 0.76 HSD17B10 (0.51) MEN1KMT2AKDM4EALDH1A1GAA
Hydrochloric Acid SCHEMBL1514232 0.76 HSD17B10 (0.51) MEN1KMT2AKDM4EALDH1A1GAA
SCHEMBL7240022 0.75 SLC6A2 (0.55) SIGMAR1HTR1ASLC6A4MEN1KMT2A
SCHEMBL15546847 0.73 MEN1 (0.51) SIGMAR1HTR1ASLC6A4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1627871-B1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE ASKA PHARM CO LTD (JP) 2010-04-14 EP disclosed
US-7449466-B2 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2008-11-11 US disclosed
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2006-08-24 US disclosed
EP-1627871-A1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE Teikoku Hormone Mfg. Co., Ltd. (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative SHBG, STS, ARSA SIGMAR1 1062/4885HTR1A 2511/4885SLC6A4 1148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.